PE anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_PE_021606
C57BL/6 mouse splenocytes stained with 17A2 PE
  • 17A2_PE_021606
    C57BL/6 mouse splenocytes stained with 17A2 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
100205 50 µg 49€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100206 200 µg 115€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Xu C, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.071. PubMed
  2. Zuchtriegel G, et al. 2016. PLoS Biol. 14: 1002459. PubMed
  3. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  4. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  5. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  6. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  7. Shen S, et al. 2018. Pain Med. 19:686. PubMed
  8. Ushijima M, et al. 2018. Front Immunol. 9:243. PubMed
  9. Correa S, et al. 2020. ACS Nano. 2224:14. PubMed
  10. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  11. Reboldi A, et al. 2016. Sci Transl Med. 352: aaf4822. PubMed
  12. Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed
  13. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  14. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  15. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  16. Bedi B, et al. 2012. Proc Natl Acad Sci U S A. 109:275. PubMed
  17. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  18. Al-Rifai R, et al. 2022. Nat Commun. 13:6592. PubMed
  19. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  20. Lutzmann M, et al. 2019. Cell Rep. 28:2851. PubMed
  21. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  22. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  23. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  24. Kuang Z, et al. 2020. Antib Ther. 3:227. PubMed
  25. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  26. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  27. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  28. Yan X, et al. 2022. Int J Biol Sci. 18:585. PubMed
  29. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  30. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  31. Ma C, et al. 2018. Science. 360:eaan5931. PubMed
  32. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  33. Schmidt D, et al. 2016. PLoS One. 11: 0159059. PubMed
  34. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  35. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  36. Biram A, et al. 2020. Cell Rep. 30:1910. PubMed
  37. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  38. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  39. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  40. Zhou Y, et al. 2022. Nat Commun. 13:2906. PubMed
  41. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
  42. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  43. Stutchfield B, et al. 2015. Gastroenterology. 149: 1896-1909.e14. PubMed
  44. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  45. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  46. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  47. Goldman E, et al. 2021. Cells. 10:. PubMed
  48. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  49. Wu J, et al. 2020. Immunity. 53:115. PubMed
  50. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  51. Lin H, et al. 2019. Infect Immun. 87:e00055-19. PubMed
  52. Pedraza–Zamora CP, et al. 2017. Parasite Immunol. 39:4. PubMed
  53. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  54. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  55. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  56. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  57. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  58. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  59. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  60. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  61. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  62. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  63. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  64. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  65. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  66. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  67. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  68. O'Connor T, et al. 2020. Cancer Cell. 36(3):250-267. PubMed
  69. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  70. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  71. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  72. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  73. Pedraza-Zamora C, et al. 2017. Parasite Immunol. 10.1111/pim.12420. PubMed
  74. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  75. Cho K, et al. 2021. iScience. 24:103117. PubMed
  76. Zhou Z, et al. 2022. Infect Immun. 90:e0045321. PubMed
  77. Bullard BL, et al. 2022. NPJ Vaccines. 7:65. PubMed
  78. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  79. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  80. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  81. Lewandowski JP, et al. 2020. Genome Biol. 1.039583333. PubMed
  82. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  83. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  84. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  85. Rozanski C, et al. 2015. J Immunol. 194:4717. PubMed
  86. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  87. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  88. Sun J et al. 2018. Cell stem cell. 23(3):355-369 . PubMed
  89. Huang L, et al. 2018. Exp Neurol. 300:41. PubMed
  90. Ding Y, et al. 2020. Evid Based Complement Alternat Med. 2020:9521073. PubMed
  91. Zhang T, et al. 2020. Cell. 180(6):1115-1129. PubMed
  92. Fang H, et al. 2020. Nat Commun. 4.661805556. PubMed
  93. Tummers B, et al. 2020. Immunity. 52(6):994-1006.e8. PubMed
  94. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  95. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  96. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  97. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  98. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  99. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  100. Yamamura K, et al. 2017. Nat Commun. 8:13946. PubMed
  101. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  102. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  103. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  104. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  105. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  106. Schneider A, et al. 2014. J Leukoc Biol. 96:857. PubMed
  107. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  108. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  109. Zhou T, et al. 2021. Bioact Mater. 0.734027778. PubMed
  110. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  111. Uluçkan ö, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  112. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  113. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  114. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  115. Fathman J, et al. 2010. Proc Natl Acad Sci U S A. 107:3663. PubMed
  116. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  117. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  118. Maulhardt HA, et al. 2020. Invest New Drugs. 1618:38. PubMed
  119. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  120. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  121. Gawish R, et al. 2022. Elife. 11:. PubMed
  122. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  123. Vannini N, et al. 2016. Nat Commun. 7:13125. PubMed
  124. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  125. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  126. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  127. Zeng F, et al. 2021. J Invest Dermatol. 596:141. PubMed
  128. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  129. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  130. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
RRID
AB_312662 (BioLegend Cat. No. 100205)
AB_312663 (BioLegend Cat. No. 100206)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC, IHC-F, IP, ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC, IHC-F, 3D IHC
Alexa Fluor® 488 anti-mouse CD3 17A2 FC, IHC-F, 3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC, ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC, IHC-F, IP, ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F, FC, 3D IHC, SB
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC, IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • FITC anti-mouse CD3

  • PE anti-mouse CD3

  • Purified anti-mouse CD3

  • Alexa Fluor® 647 anti-mouse CD3

  • Alexa Fluor® 488 anti-mouse CD3

  • Pacific Blue™ anti-mouse CD3

  • Alexa Fluor® 700 anti-mouse CD3

  • PerCP/Cyanine5.5 anti-mouse CD3

  • PE/Cyanine7 anti-mouse CD3

  • APC/Cyanine7 anti-mouse CD3

  • Brilliant Violet 421™ anti-mouse CD3

  • Brilliant Violet 570™ anti-mouse CD3

  • Brilliant Violet 650™ anti-mouse CD3

  • Brilliant Violet 785™ anti-mouse CD3

  • Brilliant Violet 510™ anti-mouse CD3

  • APC anti-mouse CD3

  • Ultra-LEAF™ Purified anti-mouse CD3

  • Brilliant Violet 605™ anti-mouse CD3

  • Alexa Fluor® 594 anti-mouse CD3

  • Brilliant Violet 711™ anti-mouse CD3

  • Biotin anti-mouse CD3

  • PE/Dazzle™ 594 anti-mouse CD3

  • APC/Fire™ 750 anti-mouse CD3

  • Brilliant Violet 750™ anti-mouse CD3

  • TotalSeq™-A0182 anti-mouse CD3

  • TotalSeq™-B0182 anti-mouse CD3

  • Spark Blue™ 550 anti-mouse CD3

  • Spark NIR™ 685 anti-mouse CD3

  • TotalSeq™-C0182 anti-mouse CD3

  • APC/Fire™ 810 anti-mouse CD3

  • PE/Fire™ 640 anti-mouse CD3

  • Spark YG™ 570 anti-mouse CD3

  • PE/Fire™ 700 anti-mouse CD3

  • PE/Cyanine5 anti-mouse CD3

  • Spark Blue™ 574 anti-mouse CD3 Antibody

  • Spark Violet™ 423 anti-mouse CD3

  • PE/Fire™ 810 anti-mouse CD3

  • Spark Red™ 718 anti-mouse CD3

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account